Related Experiment Videos
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B
R D Brod1, H W Flynn, J G Clarkson
1Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, School of Medicine.
Ophthalmology
|May 1, 1990
Summary
Successful treatment of endogenous Candida endophthalmitis (ECE) was achieved using vitrectomy and intravitreal amphotericin B. Early intervention significantly improved final visual acuity in patients with this fungal eye infection.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Mycology
Background:
- Endogenous Candida endophthalmitis (ECE) is a serious intraocular infection.
- Prompt diagnosis and treatment are crucial for visual preservation.
Purpose of the Study:
- To evaluate the efficacy of vitrectomy and intravitreal amphotericin B in managing culture-proven ECE.
- To assess factors influencing visual outcomes in ECE patients.
Main Methods:
- Retrospective analysis of eight consecutive ECE cases (1980-1988).
- All patients underwent vitrectomy and received intravitreal amphotericin B.
- Systemic antifungal therapy varied postoperatively; intravenous amphotericin B was avoided due to toxicity concerns.
Main Results:
- All eight ECE cases responded favorably to the treatment regimen.
- Final visual acuity was positively correlated with the time from symptom onset to treatment initiation.
- Post-treatment visual acuities included four eyes ≥ 20/50, two eyes 20/80–20/200, and two eyes < 5/200.
Conclusions:
- Vitrectomy combined with intravitreal amphotericin B offers a successful treatment strategy for ECE without evidence of disseminated disease.
- Timely antifungal therapy is a critical determinant of visual prognosis in ECE.